A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Clinical trial NCT05155332 · SUSPENDED
Trial details
- NCT number
- NCT05155332
- Sponsor
- Boehringer Ingelheim
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2027-12-13
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.